Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Circulating Tumor DNA for Risk Stratification in Lung Cancer Screening

NCT03774758 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT03774758
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03774758 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Circulating Tumor DNA for Risk Stratification in Lung Cancer Screening
Lead sponsor
University of California, San Francisco
Phase
Observational
Overall status
Recruiting
Start date
December 17, 2017
Completion date
December 31, 2030
Enrollment
1,440 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

nodule solitary pulmonary, non-small cell lung cancer